BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 12729663)

  • 1. 1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.
    Das U; Molnár J; Baráth Z; Bata Z; Dimmock JR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3484-7. PubMed ID: 18513966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
    Goldsborough AS; Handley MD; Dulcey AE; Pluchino KM; Kannan P; Brimacombe KR; Hall MD; Griffiths G; Gottesman MM
    J Med Chem; 2011 Jul; 54(14):4987-97. PubMed ID: 21657271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers.
    Braconi L; Bartolucci G; Contino M; Chiaramonte N; Giampietro R; Manetti D; Perrone MG; Romanelli MN; Colabufo NA; Riganti C; Dei S; Teodori E
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):974-992. PubMed ID: 32253945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ningalins, Pyrrole-Bearing Metabolites Isolated from Didemnum spp. Synthesis and MDR-Reversion Activity in Cancer Therapy.
    Segura-Quezada LA; Hernández-Velázquez ED; Corrales-Escobosa AR; de León-Solis C; Solorio-Alvarado CR
    Chem Biodivers; 2024 Jan; 21(1):e202300883. PubMed ID: 38010267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decennary update on applications of metal nanoparticles (MNPs) in the synthesis of nitrogen- and oxygen-containing heterocyclic scaffolds.
    Dhameliya TM; Donga HA; Vaghela PV; Panchal BG; Sureja DK; Bodiwala KB; Chhabria MT
    RSC Adv; 2020 Sep; 10(54):32740-32820. PubMed ID: 35516511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors.
    Karami M; Hasaninejad A; Mahdavi H; Iraji A; Mojtabavi S; Faramarzi MA; Mahdavi M
    Mol Divers; 2022 Oct; 26(5):2393-2405. PubMed ID: 34697701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse Electron Demand Diels-Alder Reactions of Heterocyclic Azadienes, 1-Aza-1,3-Butadienes, Cyclopropenone Ketals, and Related Systems. A Retrospective.
    Zhang J; Shukla V; Boger DL
    J Org Chem; 2019 Aug; 84(15):9397-9445. PubMed ID: 31062977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Synthetically Modified Natural Compounds on ABC Transporters.
    Dantzic D; Noel P; Merien F; Liu DX; Lu J; Han H; McKeage MJ; Li Y
    Pharmaceutics; 2018 Aug; 10(3):. PubMed ID: 30096910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.
    Dewanjee S; Dua TK; Bhattacharjee N; Das A; Gangopadhyay M; Khanra R; Joardar S; Riaz M; Feo V; Zia-Ul-Haq M
    Molecules; 2017 May; 22(6):. PubMed ID: 28587082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine Natural Products as Models to Circumvent Multidrug Resistance.
    Long S; Sousa E; Kijjoa A; Pinto MM
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of (Z)-3-aryl-3-haloenoic acids to the synthesis of (Z)-5-benzylidene-4-arylpyrrol-2(5H)-ones.
    Gupton JT; Telang N; Banner EJ; Kluball EJ; Hall KE; Finzel KL; Jia X; Bates SR; Welden RS; Giglio BC; Eaton JE; Barelli PJ; Firich LT; Stafford JA; Coppock MB; Worrall EF; Kanters RP; Keertikar K; Osterman R
    Tetrahedron; 2010 Nov; 66(47):9113-9122. PubMed ID: 21135918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.
    Wu CP; Ohnuma S; Ambudkar SV
    Curr Pharm Biotechnol; 2011 Apr; 12(4):609-20. PubMed ID: 21118092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamellarins and related pyrrole-derived alkaloids from marine organisms.
    Fan H; Peng J; Hamann MT; Hu JF
    Chem Rev; 2008 Jan; 108(1):264-87. PubMed ID: 18095718
    [No Abstract]   [Full Text] [Related]  

  • 14. Total synthesis of ningalin D.
    Hamasaki A; Zimpleman JM; Hwang I; Boger DL
    J Am Chem Soc; 2005 Aug; 127(30):10767-70. PubMed ID: 16045367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance reversal activity of key ningalin analogues.
    Soenen DR; Hwang I; Hedrick MP; Boger DL
    Bioorg Med Chem Lett; 2003 May; 13(10):1777-81. PubMed ID: 12729663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells.
    Zhang PY; Wong IL; Yan CS; Zhang XY; Jiang T; Chow LM; Wan SB
    J Med Chem; 2010 Jul; 53(14):5108-20. PubMed ID: 20560605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance reversal activity of permethyl ningalin B amide derivatives.
    Tao H; Hwang I; Boger DL
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5979-81. PubMed ID: 15546712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative.
    Méndez-Vidal C; Quesada AR
    Cancer Lett; 1998 Oct; 132(1-2):45-50. PubMed ID: 10397452
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.